Evidence map›Paper›PMID 37325331›Full record

ArticleFrontiers in public health2023

Radiation therapy for prostate cancer in Syrian refugees: facing the need for change.

Mehmet Fuat Eren, Sarah S Kilic, Ayfer Ay Eren, Sedenay Oskeroglu Kaplan, Fatma Teke, Tugce Kutuk, Beyhan Ceylaner Bicakci, Lara Hathout, Shalini Moningi, Peter Orio and 2 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 2 countries.

Mehmet Fuat ErenMarmara University Istanbul Pendik Education and Research Hospital, Istanbul, Türkiye.
Sarah S KilicTaussig Cancer Institute, Cancer Center, Cleveland Clinic, Cleveland, OH, United States.
Ayfer Ay ErenIstanbul Kartal Dr.Lutfi Kirdar Education and Research Hospital, Istanbul, Türkiye.
Sedenay Oskeroglu KaplanŞanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi, Sanliurfa, Türkiye.
Fatma TekeDicle University, Diyarbakır, Türkiye.
Tugce KutukMalatya Education and Research Hospital, Malatya, Türkiye.
Beyhan Ceylaner BicakciIstanbul Kartal Dr.Lutfi Kirdar Education and Research Hospital, Istanbul, Türkiye.
Lara HathoutRutgers Cancer Institute of New Jersey, The State University of New Jersey, New Brunswick, NJ, United States.
Shalini MoningiDana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Peter OrioDana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Banu AtalarAcibadem Maslak Hospital, Istanbul, Türkiye.
Mutlay SayanDana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi · TRHarvard University · USAcıbadem University · TRCleveland Clinic · USDana-Farber Cancer Institute · USDicle University · TRMalatya Devlet Hastanesi · TRMarmara University · TRRutgers Cancer Institute · USŞanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To report the utilization of radiation therapy in Syrian refugee patients with prostate cancer residing in Turkey. Methods and materials: A multi-institutional retrospective review including 14 cancer centers in Turkey was conducted to include 137 Syrian refugee patients with prostate cancer treated with radiation therapy (RT). Toxicity data was scored using the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0. Noncompliance was defined as a patient missing two or more scheduled RT appointments. Results: Advanced disease, defined as stage III or IV, was reported in 64.2% of patients while androgen deprivation therapy (ADT) was only administrated to 20% of patients. Conventionally fractionated RT with a median number of 44 fractions was delivered to all patients with curative intent ( Conclusion: Most Syrian refugee prostate cancer patients presented with advanced disease however ADT was seldom used. Despite the low treatment compliance rate, conventional fractionation was used in all patients. Interventions are critically needed to improve screening and increase the use of standard-of-care treatment paradigms, including hypofractionated RT and ADT.

Indexed as

Prostatic NeoplasmsRefugeesAndrogen AntagonistsHumansMaleRadiation Dose HypofractionationSyriaAndrogen Antagonistsglobal healthprostate cancerradiation therapyrefugeeSyriaTurkey

Identifiers

PMID37325331
PMCPMC10264678
OpenAlexW4378901985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.